N'-Isobutyl-N'-[2-(N-isobutyl-hydrazino)-acetyl]-hydrazinecarboxylic acid benzyl ester | 500022-43-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N'-Isobutyl-N'-[2-(N-isobutyl-hydrazino)-acetyl]-hydrazinecarboxylic acid benzyl ester
• 英文别名: benzyl N-[[2-[amino(2-methylpropyl)amino]acetyl]-(2-methylpropyl)amino]carbamate
• CAS: 500022-43-5
• 化学式: C₁₈H₃₀N₄O₃
• 分子量: 350.461
• InChiKey: KSFZQRFDASPNSV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  25
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  87.9
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N'-Isobutyl-N'-[2-(N-isobutyl-hydrazino)-acetyl]-hydrazinecarboxylic acid benzyl ester 在 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 51.0h， 生成 {N-Isobutyl-N'-[2-(N-isobutyl-hydrazino)-acetyl]-hydrazino}-acetic acid benzyl ester
  参考文献：
  名称：

  Retro Hydrazino-azapeptoids as Peptidomimetics of Proteasome Inhibitors

  摘要：

  Several groups of proteasome inhibitors are widely used to study the role of the ubiquin proteasome pathway in various cellular processes or as anticancer drugs. Peptidomimetics have been developed to circumvent problems inherent in peptides such as poor bioavailability and protease-mediated degradation, while retaining biological activity. In this study, we introduce new pseudopeptides, the retro hydrazino-azapeptoids, designed as proteasome inhibitor peptidomimetics. Their proteasome inhibitory activity and antiproliferative properties are reported here.

  DOI：

  10.1021/jm049455f
• 作为产物：
  描述：

  2-[[(2-Methylpropan-2-yl)oxycarbonylamino]-(2-methylpropyl)amino]acetic acid 在 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 51.0h， 生成 N'-Isobutyl-N'-[2-(N-isobutyl-hydrazino)-acetyl]-hydrazinecarboxylic acid benzyl ester
  参考文献：
  名称：

  Retro Hydrazino-azapeptoids as Peptidomimetics of Proteasome Inhibitors

  摘要：

  Several groups of proteasome inhibitors are widely used to study the role of the ubiquin proteasome pathway in various cellular processes or as anticancer drugs. Peptidomimetics have been developed to circumvent problems inherent in peptides such as poor bioavailability and protease-mediated degradation, while retaining biological activity. In this study, we introduce new pseudopeptides, the retro hydrazino-azapeptoids, designed as proteasome inhibitor peptidomimetics. Their proteasome inhibitory activity and antiproliferative properties are reported here.

  DOI：

  10.1021/jm049455f